Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Treatment of community-acquired pneumonia.

Lee YR, Houngue C, Hall RG.

Expert Rev Anti Infect Ther. 2015 Sep;13(9):1109-21. doi: 10.1586/14787210.2015.1060125. Epub 2015 Jun 19.

PMID:
26091895
2.

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections.

Hall RG 2nd, Michaels HN.

Infect Drug Resist. 2015 Apr 22;8:75-82. doi: 10.2147/IDR.S56691. eCollection 2015. Review.

3.

Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach.

Yue H, Nicholson SJ, Young JD, Hsieh D, Ketner RJ, Hall RG, Sackett J, Banks EC, Castoro JA, Randazzo ME.

Pharm Res. 2015 Aug;32(8):2636-48. doi: 10.1007/s11095-015-1649-7. Epub 2015 Feb 28.

PMID:
25724159
4.

In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos.

Pasipanodya JP, Hall RG 2nd, Gumbo T.

Clin Pharmacol Ther. 2015 Mar;97(3):292-7. doi: 10.1002/cpt.38. Epub 2014 Dec 27.

PMID:
25670351
5.

Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Hall RG 2nd, Blaszczyk AT, Thompson KA, Brouse SD, Giuliano CA, Frei CR, Forcade NA, Mortensen EM, Bell T, Bedimo RJ, Alvarez CA.

J Clin Pharm Ther. 2014 Dec;39(6):653-7. doi: 10.1111/jcpt.12203. Epub 2014 Sep 8.

PMID:
25200273
6.

Dosing of antibacterial agents in obese adults: does one size fit all?

Payne KD, Hall RG 2nd.

Expert Rev Anti Infect Ther. 2014 Jul;12(7):829-54. doi: 10.1586/14787210.2014.912942. Epub 2014 May 8. Review.

PMID:
24809811
7.

Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.

Alvarez CA, Giuliano CA, Haase KK, Thompson KA, Frei CR, Forcade NA, Brouse SD, Mortensen EM, Bell T, Bedimo RJ, Toups NM, Hall RG 2nd.

Am J Med Sci. 2014 Nov;348(5):371-6. doi: 10.1097/MAJ.0000000000000262.

PMID:
24762747
8.

Therapy duration and long-term outcomes in extra-pulmonary tuberculosis.

Pusch T, Pasipanodya JG, Hall RG 2nd, Gumbo T.

BMC Infect Dis. 2014 Mar 1;14:115. doi: 10.1186/1471-2334-14-115.

9.

Dosing considerations for obese patients receiving cancer chemotherapeutic agents.

Hall RG 2nd, Jean GW, Sigler M, Shah S.

Ann Pharmacother. 2013 Dec;47(12):1666-74. doi: 10.1177/1060028013509789. Epub 2013 Nov 4. Review.

PMID:
24259627
10.

Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths.

Hall RG 2nd, Swancutt MA, Meek C, Leff R, Gumbo T.

Antimicrob Agents Chemother. 2013 May;57(5):2259-64. doi: 10.1128/AAC.01490-12. Epub 2013 Mar 4.

11.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA.

BMC Pharmacol Toxicol. 2013 Feb 13;14:12. doi: 10.1186/2050-6511-14-12.

12.

Investigating the mode of action of sulfoxaflor: a fourth-generation neonicotinoid.

Cutler P, Slater R, Edmunds AJ, Maienfisch P, Hall RG, Earley FG, Pitterna T, Pal S, Paul VL, Goodchild J, Blacker M, Hagmann L, Crossthwaite AJ.

Pest Manag Sci. 2013 May;69(5):607-19. doi: 10.1002/ps.3413. Epub 2012 Oct 30.

PMID:
23112103
13.

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell T, Bedimo RJ, Alvarez CA.

BMC Infect Dis. 2012 Apr 27;12:104. doi: 10.1186/1471-2334-12-104.

14.

Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people.

Hall RG 2nd, Swancutt MA, Meek C, Leff RD, Gumbo T.

Antimicrob Agents Chemother. 2012 Mar;56(3):1502-7. doi: 10.1128/AAC.05623-11. Epub 2011 Dec 12.

15.

Community-wide assessment of protein-interface modeling suggests improvements to design methodology.

Fleishman SJ, Whitehead TA, Strauch EM, Corn JE, Qin S, Zhou HX, Mitchell JC, Demerdash ON, Takeda-Shitaka M, Terashi G, Moal IH, Li X, Bates PA, Zacharias M, Park H, Ko JS, Lee H, Seok C, Bourquard T, Bernauer J, Poupon A, Azé J, Soner S, Ovali SK, Ozbek P, Tal NB, Haliloglu T, Hwang H, Vreven T, Pierce BG, Weng Z, Pérez-Cano L, Pons C, Fernández-Recio J, Jiang F, Yang F, Gong X, Cao L, Xu X, Liu B, Wang P, Li C, Wang C, Robert CH, Guharoy M, Liu S, Huang Y, Li L, Guo D, Chen Y, Xiao Y, London N, Itzhaki Z, Schueler-Furman O, Inbar Y, Potapov V, Cohen M, Schreiber G, Tsuchiya Y, Kanamori E, Standley DM, Nakamura H, Kinoshita K, Driggers CM, Hall RG, Morgan JL, Hsu VL, Zhan J, Yang Y, Zhou Y, Kastritis PL, Bonvin AM, Zhang W, Camacho CJ, Kilambi KP, Sircar A, Gray JJ, Ohue M, Uchikoga N, Matsuzaki Y, Ishida T, Akiyama Y, Khashan R, Bush S, Fouches D, Tropsha A, Esquivel-Rodríguez J, Kihara D, Stranges PB, Jacak R, Kuhlman B, Huang SY, Zou X, Wodak SJ, Janin J, Baker D.

J Mol Biol. 2011 Nov 25;414(2):289-302. doi: 10.1016/j.jmb.2011.09.031. Epub 2011 Sep 29.

16.

Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people.

Hall RG, Swancutt MA, Gumbo T.

Antimicrob Agents Chemother. 2011 Nov;55(11):5107-12. doi: 10.1128/AAC.05193-11. Epub 2011 Aug 29.

17.

Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing.

Lopes-Serrao MD, Ussery SM, Hall RG 2nd, Shah SR.

J Oncol Pract. 2011 Jan;7(1):13-7. doi: 10.1200/JOP.2010.000045.

18.

Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?

Cooper TW, Pass SE, Brouse SD, Hall RG 2nd.

Ann Pharmacother. 2011 Feb;45(2):229-40. doi: 10.1345/aph.1P187.

PMID:
21304038
19.

Synthesis of CF3-substituted sulfoximines from sulfonimidoyl fluorides.

Kowalczyk R, Edmunds AJ, Hall RG, Bolm C.

Org Lett. 2011 Feb 18;13(4):768-71. doi: 10.1021/ol103030w. Epub 2011 Jan 14.

PMID:
21235264
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk